Plasma 1,25‐dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function
- 19 October 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 66 (1), 35-42
- https://doi.org/10.1111/j.1365-2265.2006.02680.x
Abstract
Background Primary hyperparathyroidism (PHPT) is characterized by elevated plasma levels of PTH and calcium with reduced plasma phosphate. Physiologically, renal 1α,25‐dihydroxyvitamin D [1,25(OH)2D] production is stimulated by PTH and phosphate deprivation, and inhibited by 1,25(OH)2D itself and calcium. Aim To investigate relations between circulating levels of 1,25(OH)2D, 25‐dihydroxyvitamin D (25OHD), PTH, calcium, phosphate, renal function and skeletal complications in patients with PHPT. Design Cross‐sectional study. Material Two hundred and fifty‐two consecutive hypercalcaemic Caucasian patients aged 24–91 (median 65·9) years (85·3% females) with PHPT. Results In patients with PHPT, plasma 1,25(OH)2D was increased by 27%[107 (9–250) pmol/l, median (range)] compared to controls [84 (18–172) pmol/l, P < 0·001]. In univariate models, plasma 1,25(OH)2D depended inversely on age (r = –0·23, P < 0·001) and plasma phosphate (r = –0·23, P < 0·001) and positively on plasma calcium (r = 0·14, P < 0·05), plasma 25OHD (r = 0,15, P < 0·05) and creatinine clearance rate (r = 0·32, P < 0·001). In the final multiple regression model, plasma 1,25(OH)2D depended positively on renal function (rp = 0·43, P < 0·001) and female sex (rp = 0·15, P < 0·05) but inversely on body mass index (BMI; rp = −0·23, P < 0·005) and plasma phosphate (rp = −0·18, P < 0·05). Plasma 1,25(OH)2D correlated positively with renal calcium excretion and inversely with lumbar spine bone mineral density (BMD) but was not associated with risk of fractures or renal stones. Conclusion Patients with PHPT have elevated plasma 1,25(OH)2D levels but, to a large extent, individual values overlap controls. The increase in plasma 1,25(OH)2D depends on renal function, hypophosphataemia and the female sex and is attenuated by high BMI. High plasma 1,25(OH)2D is associated with higher plasma calcium levels.Keywords
This publication has 51 references indexed in Scilit:
- Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidismClinical Endocrinology, 2005
- Journal of Bone and Mineral ResearchJournal of Bone and Mineral Research, 1991
- Journal of Bone and Mineral ResearchJournal of Bone and Mineral Research, 1991
- Renal mass and reserve of vitamin D: Determinants in primary hyperparathyroidismKidney International, 1987
- Primary hyperparathyroidism: evaluated by 47Calcium kinetics, calcium balance and serum bone‐Gla‐proteinEuropean Journal of Clinical Investigation, 1986
- Substrate-Product Relation of 1-Hydroxylase Activity in Primary HyperparathyroidismNew England Journal of Medicine, 1985
- Vitamin D deficiency and renal calcium transport in the rat.JCI Insight, 1984
- A TEST OF 1,25-DIHYDROXYVITAMIN D3SECRETORY CAPACITY IN NORMAL SUBJECTS FOR APPLICATION IN METABOLIC BONE DISEASESClinical Endocrinology, 1983
- The Importance of Circulating 1,25-Dihydroxyvitamin D in the Pathogenesis of Hypercalciuria and Renal-Stone Formation in Primary HyperparathyroidismNew England Journal of Medicine, 1980
- The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.JCI Insight, 1977